ZBH Stock Overview
Operates as a medical technology company worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
Zimmer Biomet Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$109.27 |
| 52 Week High | US$133.90 |
| 52 Week Low | US$101.47 |
| Beta | 1.02 |
| 11 Month Change | 3.87% |
| 3 Month Change | -3.66% |
| 1 Year Change | -4.01% |
| 33 Year Change | -16.12% |
| 5 Year Change | -25.44% |
| Change since IPO | 267.17% |
Recent News & Updates
Shareholders Can Be Confident That Zimmer Biomet Holdings' (NYSE:ZBH) Earnings Are High Quality
Nov 07
Results: Zimmer Biomet Holdings, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
Nov 02Recent updates
Shareholders Can Be Confident That Zimmer Biomet Holdings' (NYSE:ZBH) Earnings Are High Quality
Nov 07Results: Zimmer Biomet Holdings, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
Nov 02Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Share Price Not Quite Adding Up
Oct 03Zimmer Biomet: The Undervalued Titan Of Joint Replacements
Oct 02Zimmer Biomet Stock: Don't Jump In At The 52-Week Low
Sep 19We Like These Underlying Return On Capital Trends At Zimmer Biomet Holdings (NYSE:ZBH)
Sep 18Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24
Sep 02Zimmer Biomet Holdings (NYSE:ZBH) Seems To Use Debt Quite Sensibly
Aug 27Are Investors Undervaluing Zimmer Biomet Holdings, Inc. (NYSE:ZBH) By 45%?
Jul 15Investors Interested In Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Earnings
Jul 02Zimmer Biomet: Brighter Prospects In H2 2024
Jul 02Zimmer Biomet Holdings (NYSE:ZBH) Has Affirmed Its Dividend Of $0.24
Jun 19When Should You Buy Zimmer Biomet Holdings, Inc. (NYSE:ZBH)?
Jun 05Zimmer Biomet Holdings' (NYSE:ZBH) Dividend Will Be $0.24
May 21Zimmer Biomet Holdings: Moving Along
May 17The Return Trends At Zimmer Biomet Holdings (NYSE:ZBH) Look Promising
May 02Is Zimmer Biomet Holdings (NYSE:ZBH) Using Too Much Debt?
Mar 20Zimmer Biomet Holdings (NYSE:ZBH) Will Pay A Dividend Of $0.24
Mar 02Zimmer Biomet Holdings' (NYSE:ZBH) Strong Earnings Are Of Good Quality
Feb 15What Does Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Share Price Indicate?
Feb 11Zimmer Biomet: Weight Loss Drug Concerns Are Overblown
Feb 05A Look At The Fair Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Jan 29Zimmer Biomet: Growth Acceleration Is Likely Driven By ROSA; Initiate With 'Buy'
Jan 20Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Not Flying Under The Radar
Jan 15The Returns At Zimmer Biomet Holdings (NYSE:ZBH) Aren't Growing
Dec 31Zimmer Biomet Holdings: Visible Growth Drivers And Strong Execution
Dec 18Here's Why Zimmer Biomet Holdings (NYSE:ZBH) Can Manage Its Debt Responsibly
Dec 17Zimmer Biomet: Still Many Questions After A Solid Year So Far
Nov 26When Should You Buy Zimmer Biomet Holdings, Inc. (NYSE:ZBH)?
Nov 06Here's Why We Think Zimmer Biomet Holdings (NYSE:ZBH) Is Well Worth Watching
Oct 07Returns On Capital At Zimmer Biomet Holdings (NYSE:ZBH) Have Hit The Brakes
Sep 21Zimmer Biomet Holdings: Growth Strategies For 2023 Instill Confidence
Sep 14Calculating The Intrinsic Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Sep 06Zimmer Biomet: Guidance Raise, Better Margins In 2024 Make It A Buy
Aug 11Is Zimmer Biomet Holdings (NYSE:ZBH) A Risky Investment?
Aug 08Should You Think About Buying Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Now?
Jul 10We Ran A Stock Scan For Earnings Growth And Zimmer Biomet Holdings (NYSE:ZBH) Passed With Ease
Jun 27Slowing Rates Of Return At Zimmer Biomet Holdings (NYSE:ZBH) Leave Little Room For Excitement
Jun 13A Look At The Fair Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
May 30Zimmer Biomet: Expect Growth Momentum To Continue
May 26Is Zimmer Biomet Holdings (NYSE:ZBH) Using Too Much Debt?
May 04Shareholder Returns
| ZBH | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -0.6% | -0.4% | -1.0% |
| 1Y | -4.0% | 20.3% | 30.3% |
Return vs Industry: ZBH underperformed the US Medical Equipment industry which returned 20.9% over the past year.
Return vs Market: ZBH underperformed the US Market which returned 30.4% over the past year.
Price Volatility
| ZBH volatility | |
|---|---|
| ZBH Average Weekly Movement | 3.8% |
| Medical Equipment Industry Average Movement | 8.2% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ZBH has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: ZBH's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1927 | 18,000 | Ivan Tornos | www.zimmerbiomet.com |
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products.
Zimmer Biomet Holdings, Inc. Fundamentals Summary
| ZBH fundamental statistics | |
|---|---|
| Market cap | US$22.08b |
| Earnings (TTM) | US$1.08b |
| Revenue (TTM) | US$7.60b |
20.1x
P/E Ratio2.9x
P/S RatioIs ZBH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ZBH income statement (TTM) | |
|---|---|
| Revenue | US$7.60b |
| Cost of Revenue | US$2.13b |
| Gross Profit | US$5.46b |
| Other Expenses | US$4.38b |
| Earnings | US$1.08b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.44 |
| Gross Margin | 71.90% |
| Net Profit Margin | 14.27% |
| Debt/Equity Ratio | 53.6% |
How did ZBH perform over the long term?
See historical performance and comparison